Amedea B. Seabra | Pharmaceutical Chemistry | Excellence in Research

Published on 29/01/202529/01/2025 by Top Pharmaceutical

Amedea B. Seabra | Pharmaceutical Chemistry | Excellence in Research

Assoc. Prof. Dr Amedea B. Seabra, Universidade Federal do ABC, Brazil

Assoc. Prof. Dr. Amedea B. Seabra is a renowned researcher in Chemistry at Universidade Federal do ABC (UFABC), Brazil. With a Ph.D. from UNICAMP, she specializes in biomaterials, nitric oxide release, and drug delivery systems. Her research includes developing novel materials for medical applications, such as nitric oxide-releasing hydrogels and vascular prostheses. Dr. Seabra has contributed significantly to projects related to wound healing and cardiovascular health. She has received numerous accolades, including recognition in global scientific databases and awards for her work on antimicrobial silver nanoparticles. 🌟🔬💉📚🌍

Publication Profile

Google Scholar

Academic Excellence

Assoc. Prof. Dr. Amedea B. Seabra holds a PhD in Chemistry from Universidade Estadual de Campinas (UNICAMP) and completed postdoctoral research at Concordia University and UNICAMP. Specializing in the controlled release of drugs, biomaterials, and nitric oxide chemistry, she has made significant contributions to both basic and applied sciences. Dr. Seabra’s work bridges the gap between research and practical applications, particularly in advancing drug delivery systems and exploring innovative biomaterials. Her research continues to have a profound impact on the development of therapeutic strategies for various medical challenges. 🧪💊🔬🌍

Professional Engagement

Assoc. Prof. Dr. Amedea B. Seabra is a distinguished academic with a wealth of experience in the field of biotechnology. Currently, she serves as the Vice Coordinator at the UFABC Graduate Program in Biotechnology and works as a collaborative researcher at the University of Edinburgh. Dr. Seabra has actively contributed to various international projects, including the prestigious Newton Advanced Fellowship. Her dedication to advancing research and fostering global collaborations highlights her commitment to scientific progress. 🌍🔬👩‍🔬💡

Awards and Recognition

Assoc. Prof. Dr. Amedea has made remarkable contributions to the scientific community, earning widespread recognition for her work. She was included in the prestigious Top 100,000 Scientists by C-Score and named among the most influential scientists globally in 2023 by Elsevier and Stanford University. Her exceptional achievements reflect her dedication and impact in her field. 🌍🔬📚🌟 Her ongoing research continues to inspire and drive advancements, solidifying her place as a leading figure in the scientific world. 👩‍🔬✨

Research Focus

Assoc. Prof. Dr. Amedea B. Seabra’s research focuses on nanotechnology, particularly the toxicology and antimicrobial properties of nanoparticles. Her studies investigate the synthesis, characterization, and biological effects of metal nanoparticles, such as silver and copper, including their cytotoxicity, genotoxicity, and environmental hazards. She has explored the potential of biogenically synthesized nanoparticles and their application in medicine, such as antimicrobial activity and toxicity in model organisms. Her work extends to the use of cellulose nanocrystals in medicine and addresses the risks posed by metal oxide nanoparticles. Overall, her research contributes to the safe application of nanomaterials. 🧬🧪⚛️

Publication Top Notes

Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity

Nanotoxicity of graphene and graphene oxide

Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles

Green tea extract mediated biogenic synthesis of silver nanoparticles: Characterization, cytotoxicity evaluation and antibacterial activity

In vitro antifungal efficacy of copper nanoparticles against selected crop pathogenic fungi

Silver nanoparticles: Toxicity in model organisms as an overview of its hazard for human health and the environment

S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance

Antimicrobial activity of biogenic silver nanoparticles, and silver chloride nanoparticles: an overview and comments

Biogenic nanoparticles: copper, copper oxides, copper sulphides, complex copper nanostructures and their applications

Thermal and photochemical nitric oxide release from S-nitrosothiols incorporated in Pluronic F127 gel: potential uses for local and controlled nitric oxide release

Ali Olad | Drug Delivery Systems | Best Researcher Award

Published on 28/01/202528/01/2025 by Top Pharmaceutical

Ali Olad | Drug Delivery Systems | Best Researcher Award

Prof Ali Olad, University of Tabriz, Iran

Prof. Ali Olad is a distinguished researcher in applied chemistry, specializing in polymer composites, conducting polymers, and polymeric coatings. 🎓 He earned his Ph.D. in Applied Chemistry (2003) from the University of Tabriz, where he continues to teach courses on industrial chemistry, polymer nanocomposites, and coatings. 📚 His research focuses on nanocomposites, conducting polymers, corrosion resistance, and environmental pollutant detection. 🌱🧪 Prof. Olad has presented groundbreaking work globally, authored influential books, published high-impact papers, and holds patents on polyaniline nanostructures and advanced materials. 🏆💡 His innovations in hydrogels, fertilizers, and sensors reflect his commitment to sustainable and practical chemical solutions. 🌍✨

Publication Profile

Google Scholar

Educational Background

Prof. Ali Olad is a distinguished academic specializing in Applied Chemistry, with a focus on polymer composites, conducting polymers, and corrosion-resistant polymeric coatings. 🎓 He earned his Ph.D. in Applied Chemistry (Polymer Composites & Conducting Polymers) from the University of Tabriz, Iran, in 2003. 📘 Prior to this, he completed his M.Sc. in Applied Chemistry (Corrosion & Polymeric Coatings) in 1997 and his B.Sc. in Applied Chemistry in 1995, both from the same institution. 🔬 His expertise and academic achievements contribute significantly to advancements in materials science, fostering innovative research and practical applications in the field. 🌟

Experience

Prof. Ali Olad has a remarkable teaching career at the University of Tabriz, offering diverse courses across various academic levels. He has taught Conducting Polymers at the Ph.D. level (2006–2010) and Industrial Chemistry 2 at the B.Sc. level since 1997. Additionally, he lectured on Industrial Electrochemistry (2003–2017). Prof. Olad continues to teach Coatings and Adhesives (Ph.D.), Polymer Composites and Nanocomposites (M.Sc.), and Physical and Mechanical Properties of Polymers (M.Sc.) since 2010. His dedication to education and expertise in polymers, nanocomposites, and industrial chemistry have greatly contributed to the field. 🎓📚🧪✨

Research Interests

Prof. Ali Olad specializes in the fields of polymer composites and nanocomposites, focusing on their development and applications. His expertise extends to surface modification and polymer coatings, enhancing material performance. Additionally, he works on conducting polymers and blends, exploring their conductive properties. Prof. Olad’s research also delves into polymer hydrogels, investigating their potential in various biomedical and industrial applications. Furthermore, he studies corrosion and electrochemistry, aiming to improve material durability and sustainability. His contributions to these areas have led to advancements in materials science and engineering. 🌐🔬🧪💡🛠️

Research Focus

The individual behind these publications appears to have a research focus in materials science, environmental engineering, and nanocomposites, with particular attention to polymers, hydrogel systems, and waste treatment technologies. Their work spans a range of topics such as electrocoagulation for dye removal, slow-release fertilizers, and anti-corrosion coatings, with an emphasis on nanocomposite materials like clay-polymers, superabsorbent hydrogels, and conductive polymers. This person is also involved in environmental cleanup and water treatment, exploring methods to improve water quality by utilizing advanced materials and nanotechnology 🧪🌍💧🔬.

Publication Top Notes

Decolorization of basic dye solutions by electrocoagulation: An investigation of the effect of operational parameters

Slow-released NPK fertilizer encapsulated by NaAlg-g-poly (AA-co-AAm)/MMT superabsorbent nanocomposite

Anti-corrosive properties of polyaniline coating on iron

Slow-release NPK fertilizer encapsulated by carboxymethyl cellulose-based nanocomposite with the function of water retention in soil

Polymer-clay nanocomposites

Superabsorbent hydrogel made of NaAlg-g-poly (AA-co-AAm) and rice husk ash: Synthesis, characterization, and swelling kinetic studies

On the preparation and swelling properties of hydrogel nanocomposite based on Sodium alginate-g-Poly (acrylic acid-co-acrylamide)/Clinoptilolite and its …

Removal of chromium from aqueous solution using polyaniline–poly ethylene glycol composite

Optimization of electrocoagulation process for removal of an azo dye using response surface methodology and investigation on the occurrence of destructive side reactions

Preparation and anticorrosive properties of PANI/Na-MMT and PANI/O-MMT nanocomposites

The synergetic effect of bioactive ceramic and nanoclay on the properties of chitosan–gelatin/nanohydroxyapatite–montmorillonite scaffold for bone tissue engineering

Dipanjan Karati | Drug Discovery and Development | Best Researcher Award

Published on 28/01/202528/01/2025 by Top Pharmaceutical

Dipanjan Karati | Drug Discovery and Development | Best Researcher Award

Dr Dipanjan Karati, Techno India University, West Bengal, India

Dr. Dipanjan Karati is an Assistant Professor at Techno India University, West Bengal, with expertise in pharmaceutical chemistry. He holds a M. Pharm (2021) from Bharati Vidyapeeth University and a B. Pharm (2019) from MAKAUT, both with distinction. His research focuses on neurodegenerative diseases and antimicrobial agents, with several publications in prestigious journals. Dr. Karati has actively participated in numerous seminars, webinars, and workshops. He is a GPAT 2019 qualifier and has industrial training at Glenmark Pharmaceuticals. He is passionate about academics and research in the field of drug development. 📚💊🧠🔬👨‍🔬

Publication Profile

Google Scholar

Academic Excellence

Dr. Dipanjan Karati is a highly qualified pharmaceutical professional with a strong academic background. He completed his M. Pharm in Pharmaceutical Chemistry from Poona College of Pharmacy, Bharati Vidyapeeth University, Pune, in 2021, securing a first-class distinction with an 8.09 CGPA. Prior to that, he earned his B Pharm from NSHM Knowledge Campus, Kolkata, in 2019, with an outstanding 80.2% (1st class with distinction). Dr. Karati completed his HSC in 2013 with 81.2% and SSC in 2011 with 78.125% from Garh Bhawanipur RP Institution, Howrah. His consistent academic performance highlights his dedication to the pharmaceutical field. 📚💊🎓

Research Project

Dr. Dipanjan Karati’s research focuses on the “In Silico Design, Synthesis, and Evaluation of Novel Schiff Base Congeners as Neurodegenerative and Antimicrobial Agents.” His objective is to design and synthesize innovative pyrimidine derivatives containing a nitrile group and substituted Schiff bases with azomethine groups. These compounds are being explored for their potential in treating neurodegenerative diseases and exhibiting antimicrobial properties. Dr. Karati’s work combines advanced computational techniques and experimental synthesis to develop effective therapeutic agents, aiming to contribute significantly to the fields of neurodegenerative diseases and antimicrobial resistance. 🔬🧠💊🦠💡

Experience

Dr. Dipanjan Karati has an impressive academic and professional background in the pharmaceutical field. He completed his Industrial Training at Glenmark Pharmaceutical Limited from January 9th to 23rd, 2018, gaining valuable industry experience. He served as an Assistant Professor at Gitanjali College of Pharmacy in Lohapur, Birbhum, for one year, contributing to the academic development of students. Currently, Dr. Karati holds the position of Assistant Professor at the School of Pharmacy, TIU, since September 2022, continuing his dedication to education and research. 📚💊👨‍🏫

Achievements and Awards

Dr. Dipanjan Karati achieved a significant milestone by qualifying for the All India Graduate Pharmacy Aptitude Test (GPAT) in 2019, showcasing his dedication and expertise in the field of pharmacy. 🏆📚 This prestigious achievement highlights his academic excellence and potential for contributing to pharmaceutical sciences. 🌟💊 With his strong foundation and passion for research, Dr. Karati is committed to advancing innovations in pharmacy and healthcare. 🚀🔬 His GPAT qualification is a testament to his hard work and determination, inspiring others in the field to strive for academic and professional success. 🌱🎓

Research Focus

Dr. Dipanjan Karati’s research focuses on medicinal chemistry, pharmacognosy, and drug discovery. His studies emphasize exploring bioactive compounds from plants 🌱, such as Ficus racemosa and Zingiber officinale, for their pharmacological properties including anti-inflammatory, anticancer, and antimicrobial activities 🧪🩺. He investigates synthetic scaffolds like pyrazoles and benzimidazoles for designing innovative therapies targeting diseases such as cancer, malaria, and infections 🎯🧬. Dr. Karati also explores bio-responsive polymers for targeted drug delivery and examines natural products like Cordyceps sinensis for therapeutic potential 🍄🔬. His work bridges natural products and modern medicinal approaches, advancing personalized treatments 🌟📖.

Publication Top Notes

Alkylating agents, the road less traversed, changing anticancer therapy

Pyrazole Scaffolds: centrality in anti-inflammatory and antiviral drug design

Exploring the pharmacognostic properties and pharmacological activities of phytocompounds present in Ficus racemosa linn.: A concise review

A molecular insight into pyrazole congeners as antimicrobial, anticancer, and antimalarial agents

Plant Bioactives in the Treatment of Inflammation of Skeletal Muscles: A Molecular Perspective

In-silico investigation and drug likeliness studies of benzimidazole congeners: the new face of innovation

Exploring the phytochemistry, pharmacognostic properties, and pharmacological activities of medically important plant Momordica charantia

AASHAQ HUSSAIN BHAT | Herbal Medicine and Nutraceuticals | Best Researcher Award

Published on 28/01/202528/01/2025 by Top Pharmaceutical

AASHAQ HUSSAIN BHAT | Herbal Medicine and Nutraceuticals | Best Researcher Award

Assist. Prof. Dr AASHAQ HUSSAIN BHAT, Chandigarh University, India

🌍 Assistant Professor at Chandigarh University, India, and Adjunct Faculty at Saveetha University, Chennai. Dr. Bhat specializes in entomopathogenic nematodes, ecology, and biocontrol. He completed his PhD in Zoology at Chaudhary Charan Singh University, India, with multiple awards, including the Dr. Motilal Dalela Gold Medal and Early Career Bursary by the Society of Nematologists. With numerous publications and international recognition, Dr. Bhat is an expert in molecular biology, nematode taxonomy, and biocontrol strategies. He is actively engaged in research and is a jury member for science initiatives. 📚🔬

Publication Profile

google scholar

Education

Assist. Prof. Dr. Aashaq Hussain Bhat has an impressive academic journey, with a Ph.D. in Zoology from Chaudhary Charan Singh University, Meerut (2014-2019). He earned his Master of Philosophy (M.Phil.) in Zoology from the same institution in 2012-2013 with 73% marks. His Master’s degree in Zoology (2010-2012) was completed with 75.02% marks. Earlier, Dr. Bhat obtained his Bachelor of Science in Biology from the University of Kashmir (2007-2009) with 67.6% marks. His secondary education was completed at Government Higher Secondary School Hardutoru (2005-2006) with 74%, and high school at the same institution (2003-2004) with 82.4% marks. 📚🎓

Professional position

Dr. Aashaq Hussain Bhat is an accomplished academician and researcher. Currently, he serves as an Assistant Professor at the University Centre for Research and Development, Chandigarh University, Mohali (2023-present) and as an Adjunct Faculty at Saveetha Dental College, Saveetha University, Chennai (2023-present). Dr. Bhat’s previous roles include Postdoctoral Fellow under the Swiss Government Excellence Scholarship at the University of Neuchâtel, Switzerland (2021-2022), Assistant Professor at Government Degree College, Jammu and Kashmir (2020-2021), and Guest Lecturer at Chaudhary Charan Singh University, Meerut (2017-2020). He was also awarded the DST-Inspire Fellowship by the Government of India (2014-2019). 🎓🌍📚

Honors and Awards

Dr. Aashaq Hussain Bhat has received numerous prestigious honors and awards throughout his career. Notably, he was a Jury Member for the World’s First Science Reality Show, Vigyan Ghar Season-2 (2018), and earned the Dr. Motilal Dalela Gold Medal for his research on Steinernema siamkayai in Integrated Pest Management (2018). He has been awarded the Early Career Bursary by the Society of Nematologists (2019), and the Best Oral Presentation Award for his work on Steinernema abbasi (2019). Dr. Bhat was also recognized with the Young Scientist Gold Medal (2015) and MSc Topper Gold Medal (2012). 🏅🎤📚

Member of scientific bodies

Assist. Prof. Dr. Aashaq Hussain Bhat is an esteemed academic and researcher with notable memberships in prominent scientific associations. He is a life member of the Indian Science Congress Association (INCA) 🧑‍🔬, which connects scientists from various disciplines. Dr. Bhat is also an active member of the European Society of Nematologists (ESN) 🪱, contributing to advancements in nematology. Additionally, he is a member of The Society of Chemical Industry (SCI) ⚗️, an organization that fosters innovation and collaboration in the chemical industry. These memberships reflect his dedication to scientific research and his commitment to global scientific progress.

Research Focus

Assoc. Prof. Dr. Aashaq Hussain Bhat’s research primarily revolves around entomopathogenic nematodes and their role in biological pest control. His studies extensively cover Steinernema and Heterorhabditis species, exploring their morphology, molecular characterization, and ecological distribution. Dr. Bhat is also focused on the bacterial symbionts of these nematodes and their potential in controlling agricultural pests. His work includes studies on bacterial zoonoses, antimicrobial resistance, and the broader implications of nematode-bacteria symbiosis in pest management. Through his research, Dr. Bhat contributes significantly to the sustainable agricultural practices and biological control sectors 🌱🐛

Publication Top Notes

Global distribution of entomopathogenic nematodes, Steinernema and Heterorhabditis

Bacterial zoonoses transmitted by household pets and as reservoirs of antimicrobial resistant bacteria

First report and comparative study of Steinernema surkhetense (Rhabditida: Steinernematidae) and its symbiont bacteria from subcontinental India

Study of Steinernema hermaphroditum (Nematoda, Rhabditida), from the West Uttar Pradesh, India

The first report of Xenorhabdus indica from Steinernema pakistanense: co-phylogenetic study suggests co-speciation between X. indica and its steinernematid nematodes

Description of Heterorhabditis bacteriophora (Nematoda: Heterorhabditidae) isolated from hilly areas of Kashmir Valley

Mahshid Malakootian | Cardiovascular Pharmacology | Best Researcher Award

Published on 27/01/202527/01/2025 by Top Pharmaceutical

Mahshid Malakootian | Cardiovascular Pharmacology | Best Researcher Award

Assoc. Prof. Dr Mahshid Malakootian, Rajaie cardiovascular medical and research center, Iran

Born on March 21, 1981, in Tehran, Iran, Dr. Mahshid Malakootian is a distinguished molecular geneticist and Associate Professor at Rajaie Cardiovascular Medical & Research Institute, Tehran. A prolific researcher, she specializes in non-coding RNAs, cardiovascular genetics, and bioinformatics. She completed her Ph.D. in Molecular Genetics at Tarbiat Modares University and held postdoctoral fellowships at McGill University and Case Western Reserve University. Dr. Malakootian has published extensively and received numerous accolades, including Best Young Researcher awards. Fluent in English and Persian, she is a dedicated academic, head of the Cardiogenetic Research Center, and an editorial board member. 📚🧬🌍

Publication Profile

google scholar

Academic Excellence

Assoc. Prof. Dr. Mahshid Malakootian is a distinguished expert in molecular genetics and cardiogenetics, contributing significantly to the field. Since 2021, she has served as an Associate Professor at the Cardiogenetic Research Center, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran. 💡 From 2018, she has led the center as its Head, advancing groundbreaking research in cardiovascular genetics. 🧬 Previously, she was an Assistant Professor from 2015 to 2021 and has been an active board member of the Research Deputy since 2015, shaping impactful scientific initiatives. 📚 Her work continues to drive innovation in cardiovascular health. ❤️

Research Experience

Assoc. Prof. Dr. Mahshid Malakootian is an accomplished molecular geneticist with extensive research experience. She pursued her post-doctorate in Experimental Medicine at McGill University, Canada (2016-2017), focusing on PCSK7 RNA regulators 🧬. Previously, she was a post-doctoral fellow at Tarbiat Modares University, Tehran (2014-2015), and a visiting research scholar at Case Western Reserve University, USA (2011-2012) 🔬. Dr. Malakootian earned her Ph.D. (2009-2014) and M.Sc. (2004-2007) in Molecular Genetics at Tarbiat Modares University, where she explored non-coding RNAs and tumorigenesis. Her academic journey began with a B.Sc. in Cellular and Molecular Sciences from the University of Tehran (1999-2003) 🧪.

Honors and Awards

Assoc. Prof. Dr. Mahshid Malakootian is an award-winning researcher recognized for her outstanding contributions in molecular genetics and stem cell technology. 🏆 She has earned accolades such as the “Best Young Researcher” award (2017, 2019) and the “Top Thesis Award” (2014). 🎖 Her pioneering research is supported by multiple grants, including studies on noncoding RNAs and cardiovascular biomarkers. She has discovered and sequenced numerous novel genetic variants, published in GenBank, and co-authored a U.S. patent for miR-her2-1, aiding breast and ovarian cancer diagnostics. 💡📚 A scholar of exceptional caliber, Dr. Malakootian remains a trailblazer in biomedical innovation. 🌟

Professional Societies

Assoc. Prof. Dr. Mahshid Malakootian is an accomplished scientist and an active member of prestigious organizations, including the American Association for Cancer Research (AACR) 🌟, the Iranian Genetics Society (IGS) 🧬, and the Iranian Biotechnology Society 🌿. Her dedication to advancing research is reflected in her role as an editorial board member of the Environmental Health Engineering and Management Journal 📚. With her extensive expertise and contributions, she continues to shape the fields of cancer research, genetics, and biotechnology, fostering innovative solutions for global health challenges 🌍. Dr. Malakootian’s work exemplifies excellence and inspires the scientific community. ✨

Teaching Experience

Associate Professor Dr. Mahshid Malakootian is a distinguished expert in molecular genetics at Shahed University, where she also leads the Advanced Molecular Genetics Lab Course 🧬. Her dedication to education and research has inspired countless students and colleagues. Dr. Malakootian has honed her expertise as a research assistant in Dr. Mowla’s laboratory, contributing to cutting-edge discoveries in molecular genetics 🔬. With a passion for advancing knowledge, she has made significant strides in her field, combining academic excellence with hands-on laboratory experience. Her work continues to shape the future of genetic research and education, making her a respected figure in the scientific community.

Research Focus

Assoc. Prof. Dr. Mahshid Malakootian focuses on cutting-edge research in microRNAs, cardiovascular diseases, and non-coding RNAs in various biological and pathological contexts. Her work explores microRNA roles in cardiovascular development, post-transcriptional regulation, and cancer biology, particularly lung and esophageal tumors. Dr. Malakootian also investigates long non-coding RNAs (lncRNAs), circular RNAs, and their interplay in genetic regulation and disease pathways. Her studies on epigenetics and innovative therapeutic approaches significantly impact cardiovascular health and cancer treatment. 🧬🩺🫀

Publication Top Notes

MicroRNAs: roles in cardiovascular development and disease

Post-transcriptional regulation of PCSK9 by miR-191, miR-222, and miR-224

Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors

Ciprofloxacin removal from aqueous media by adsorption process: a systematic review and meta-analysis

Pathophysiology, Diagnosis, Treatment, and Genetics of Carpal Tunnel Syndrome: A Review

Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma

Overexpression of BMI1, a polycomb group repressor protein, in bladder tumors: a preliminary report

Differential expression of nucleostemin, a stem cell marker, and its variants in different types of brain tumors

lncRNA PSORS1C3 is regulated by glucocorticoids and fine-tunes OCT4 expression in non-pluripotent cells

Serefnur Ozturk | Clinical Trials | Women Researcher Award

Published on 25/01/202525/01/2025 by Top Pharmaceutical

Serefnur Ozturk | Clinical Trials | Women Researcher Award

Prof Serefnur Ozturk, Selcuk University Faculty of Medicine, Turkey

Prof. Şerefnur Öztürk is a leading expert in Neurology and Neurointensive Care, currently serving as the Head of the Neurology Department at Selcuk University, Turkey. She has held prominent roles including Vice Dean of the Faculty of Medicine (1996-2020) and President of the Turkish Neurological Society (2014-2021). With significant international influence, she contributes to the European Academy of Neurology and World Stroke Organization. She has led pivotal projects and trials in stroke and COVID-19-related neurological care. Prof. Öztürk is an acclaimed researcher with numerous influential publications in neurology.

Publication Profile

scopus

Education

Prof. Serefnur Ozturk has an impressive educational background. She began her medical studies at Ankara University Medical Faculty, where she earned her degree between 1980 and 1987. Her academic journey continued with a prestigious NATO Fellowship at Arizona University’s Stroke Center in 1993, further enhancing her expertise. In 1998, she advanced her knowledge in neurology and intensive care at Pittsburgh University, where she studied in their renowned Neurology and Intensive Care Department. These experiences have shaped Prof. Ozturk into a leading figure in her field. 🏥🎓🧠

Internship and Residencies

Prof. Serefnur Ozturk completed her internship at Ankara University Medical Faculty, where she gained valuable hands-on experience. Following this, she pursued her residency at Ankara Numune Research and Education Hospital, further honing her medical skills. Prof. Ozturk’s dedication to her field is reflected in her board certification, earning the Turkish Neurological Board Council Certificate. This certification recognizes her extensive expertise in neurology, solidifying her status as a trusted professional in her area of specialization. Her journey through internships, residencies, and board certification showcases her commitment to excellence. 🏥💉🧑‍⚕️🧠

Experiences

Prof. Serefnur Ozturk holds numerous prestigious leadership roles in neurology. She served as the President of the Turkish Neurological Society from 2014 to 2021 and is currently a member of various important committees, including the European Academy of Neurology (EAN) COVID-19 Task Force and the World Stroke Organization Global Policy Committee. Additionally, she is the Vice President of the European Environmental Neurology Society and has held positions within the World Federation of Neurology (WFN), including President of the Migrant Neurology Specialty Group. Prof. Ozturk is dedicated to advancing stroke care, cerebrovascular diseases prevention, and diversity in neurology. 🧠🌍👩‍⚕️🏥

Projects

Prof. Serefnur Ozturk has played a pivotal role in several major clinical trials and registries. She is the Principal Investigator of the EAN ENERGY COVID-19 Registry and the ENSEMBLE study, showcasing her leadership in critical research. Additionally, Prof. Ozturk serves as the National Coordinator for the Turkish COVID-19 Registry, the ENOS Trial, and TICH-2. Her expertise extends to key studies like the PERFORM Study (Phase III), FACT (Phase IV), and NAVIGATE-ESUS, where she also holds significant leadership positions. Her contributions to clinical research have greatly impacted neurology and stroke care. 🔬🧠🌍💉

Research Focus

Prof. Şerefnur Öztürk’s research focus lies predominantly in neurology, with a special emphasis on the neurological impacts of COVID-19, ischemic stroke, and innovative prognostic tools like the Selcuk Score. Her work is pivotal in advancing the understanding of how pandemics influence neurological care and the management of post-pandemic risks. Additionally, Prof. Öztürk contributes to cutting-edge stroke prevention and rehabilitation technologies, including web-based solutions. Her contributions drive progress in neuro-COVID research, stroke management, and global neurological health policies, showcasing her commitment to improving outcomes for patients worldwide. 🌍🧠💻

Publication Top Notes

The European Academy of Neurology NeuroCOVID-19 Task Force: A lesson for the future

Muscle mass as a modifier of stress response in acute ischemic stroke patients

Management of patients with neurological diseases considering post-pandemic coronavirus disease 2019 (COVID-19) related risks and dangers — An updated European Academy of Neurology consensus statement

The Effect of Tranexamic Acid on Neurosurgical Intervention in Spontaneous Intracerebral Hematoma: Data from 121 Surgically Treated Participants from the Tranexamic Acid in IntraCerebral Hemorrhage-2 Randomized Controlled Trial

General neurology: Current challenges and future implications

Climate Change and Stroke: A Topical Narrative Review

Ashenafi Sendekie | Pharmaceutical Policy and Regulation | Best Researcher Award

Published on 25/01/202525/01/2025 by Top Pharmaceutical

Ashenafi Sendekie | Pharmaceutical Policy and Regulation | Best Researcher Award

Mr Ashenafi Sendekie, Curtin University, Australia

Mr. Ashenafi Kibret Sendekie is a dedicated researcher and academic pursuing a Ph.D. at Curtin University, focusing on ethical dilemmas in pharmacist-administered vaccinations for children and adolescents. 🎓 He holds a Master’s in Clinical Pharmacy and a Bachelor’s in Pharmacy from the University of Gondar. 📚 With numerous publications in SJR Q1 journals, his research spans AI in pharmacy, mental health, and public health. 🧠 As a lecturer and former Head of Hospital Pharmacy, he excels in teaching, leadership, and community service. 💊 His commitment to healthcare ethics and professional development makes him a standout in pharmacy research. 🌍

Publication Profile

google scholar

Education

Ashenafi Sendekie is a dedicated scholar currently pursuing a Ph.D. in Pharmacy at Curtin University, Australia 🇦🇺 (2024–present). His research focuses on exploring pharmacists’ experiences and ethical dilemmas in administering vaccines to children and adolescents using a mixed-methods approach 💉📊. He earned a Diploma in Teaching Methodology from the University of Gondar, Ethiopia 🇪🇹 (2020–2021), and an MSc in Clinical Pharmacy from the same institution (2018–2020) 🧪📚. Ashenafi began his academic journey with a Bachelor of Science in Pharmacy from the University of Gondar (2009–2014) 🎓. His commitment to pharmacy and education exemplifies his passion for improving healthcare outcomes 🌟.

Professional Membership

Ashenafi Sendekie is a proactive professional serving as the Chairperson of the Ethiopian Pharmaceutical Association (EPA), Gondar Chapter Executive Committee, since January 2023 🌍💊. He is also an active member of the Ethiopian Public Health Association (EPHA) 🏥. Ashenafi is known for his exceptional skills, including being a fast learner 🧠, maintaining a positive attitude 🌟, and excelling in time management ⏳ and attention to detail 🔍. His strong communication skills 🗣️, reliability ⏰, computer proficiency 💻, and teamwork 🤝 make him a valuable asset in any setting. Ashenafi’s organizational expertise ensures efficiency and success in his endeavors 📋✔️.

Journals Reviewer

Ashenafi Sendekie has actively contributed to renowned international journals as an author and researcher 🖋️🌍. His work is featured in prestigious publications, including PLOS Global Public Health 🌐, BMJ Open 📖, and Nature (Scientific Reports) 🔬. He has also contributed to journals like Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 🩺, Patient Preference and Adherence 💊, and BMC Health Services Research 🏥. Other notable journals include F1000Research 🔎, BMC Endocrine 💡, Integrated Pharmacy Research and Practice ⚕️, and BMJ Open Respiratory Research 🌬️. Ashenafi’s scholarly efforts reflect his commitment to advancing global health and pharmacy research 📚✨.

Collaboration

Ashenafi Sendekie is a committed contributor to the Global Burden of Disease (GBD) Collaboration 🌍📊, based at the Institute for Health Metrics and Evaluation (Hans Rosling Center for Population Health) in Seattle, WA, USA 🇺🇸. Since December 17, 2024, he has served as a GBD Senior Collaborator 🌟, following his role as a GBD Collaborator from April 2023 to December 16, 2024 📈. Ashenafi’s work in this global initiative highlights his dedication to advancing population health and contributing to impactful research aimed at improving health outcomes worldwide 🌐✨.

Conferences

Ashenafi Sendekie has actively participated in key academic events and presented his work on an international stage 🌍🎤. He presented a paper at the 5th Annual Conference of the Australian-based Ethiopian Researchers Network (ABReN) on August 31, 2024 📅. He also took part in the International Pharmaceutical Federation (FIP) PPR SIG 2024 Virtual Meeting on July 4, 2024 💻. Additionally, Ashenafi delivered an oral presentation at the 43rd Annual Conference of the Ethiopian Pharmaceutical Association held in Addis Ababa, Ethiopia, from July 28-29, 2023 🇪🇹💊. His active involvement highlights his commitment to advancing pharmaceutical research and knowledge sharing 📚.

Honors and Awards

Ashenafi Sendekie has received numerous prestigious awards throughout his academic journey 🎓🏆. In November 2023, he was awarded the 2024 HDR Curtin Scholarship at Curtin University, Australia 🇦🇺, providing a tuition fee offset and a stipend of $33,220 per annum for three years, with a possible six-month extension 💵. Earlier, in August 2023, he was offered admission for a Doctor of Philosophy in Pharmacy at Curtin University 🧪. In November 2022, Ashenafi received the Community Service Project Award from the University of Gondar, Ethiopia 🇪🇹, for his project improving pharmacists’ roles in patient counseling 💬. He also received research and scholarship grants for his master’s studies in clinical pharmacy 💡.

Current Residence

Ashenafi Sendekie currently resides at UniLodge at Curtin University – Guild House 🏠, located at 21.2, 63 Jackson Road, Karawara, WA, 6152, Australia 🇦🇺. This accommodation provides him with a comfortable and convenient living space close to Curtin University, supporting his academic pursuits 🧑‍🎓. As a Ph.D. student in Pharmacy, Ashenafi is able to focus on his studies while enjoying a supportive community environment at UniLodge 🌟. The location offers access to university facilities and enhances his experience as an international student in Australia 🌍.

Research Focus

Dr. Ashenafi Sendekie is a researcher with a strong focus on pharmacology, medication adherence, and chronic disease management. His work investigates the impact of medications, particularly for conditions like type 2 diabetes, asthma, and psychiatric disorders, while emphasizing patient education, medication safety, and adverse drug reactions. Dr. Sendekie also explores healthcare delivery in Ethiopia, including the roles of community pharmacists and the quality of life in patients managing chronic diseases. His research aims to improve medication adherence, reduce drug interactions, and enhance patient outcomes in low-resource settings. 🩺💊📊

Publication Top Notes

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Medication adherence and its impact on glycemic control in type 2 diabetes mellitus patients with comorbidity: A multicenter cross-sectional study in Northwest Ethiopia

Assessment of community pharmacy professionals’ knowledge and counseling skills achievement towards headache management: a cross-sectional and simulated-client based mixed study

Evaluation of antibiotics residues in milk and meat using different analytical methods

Impact of personal, cultural and religious beliefs on medication adherence among patients with chronic diseases at university hospital in Northwest Ethiopia

Potential drug-drug interactions and associated factors among admitted patients with psychiatric disorders at selected hospitals in Northwest Ethiopia

Glycemic control in newly insulin-initiated patients with type 2 diabetes mellitus: A retrospective follow-up study at a university hospital in Ethiopia

Incidence and patterns of adverse drug reactions among adult patients hospitalized in the University of Gondar comprehensive specialized hospital: A prospective observational …

SAEID ZEINALI HERIS | Antibiotic Resistance | Best Researcher Award

Published on 25/01/202525/01/2025 by Top Pharmaceutical

SAEID ZEINALI HERIS | Antibiotic Resistance | Best Researcher Award

Prof SAEID ZEINALI HERIS, Xi’an University od Science nd Technology, China

Prof. SAEID ZEINALI HERIS is an accomplished chemical engineer with a Ph.D. from Isfahan University of Technology. His expertise includes nanofluids, heat transfer, and thermophysical properties. He has been recognized as a top 1% active scientist in engineering from 2016-2023. Prof. Zeinali Heris serves as an Associate Editor for several scientific journals and has led numerous industrial and research projects related to nanomaterials, gas refineries, and energy efficiency. He currently teaches at Xi’an University of Science and Technology and has extensive experience in academic and industrial research. 🌍📚⚙️🔬

Publication Profile

google scholar

Education

Prof. SAEID ZEINALI HERIS holds a Ph.D. in Chemical Engineering from Isfahan University of Technology (2000-2006), where his thesis focused on the experimental investigation of nanofluid laminar flow convective heat transfer through circular tubes under constant wall temperature. He also earned his M.Sc. in Chemical Engineering from the same university (1997-1999), with a thesis on the mathematical calculation and construction of a falling cylinder rheometer. Prof. Zeinali Heris completed his B.S. in Chemical Engineering at the University of Tehran (1992-1996). His work combines theoretical and experimental methods in chemical engineering. 🎓🔬🔥

Experience

Prof. SAEID ZEINALI HERIS is a distinguished academic and researcher currently serving at Xi’an University of Science and Technology (2022-present). He has an extensive career, including roles as the Head of the Faculty of Chemical and Petroleum Engineering at the University of Tabriz (2018-2022), and Vice-Chancellor of the same faculty (2017-2018). A professor since 2015, he has also held key management positions such as Manager of IAChE’s North & East Branch. Prof. Zeinali’s work spans various research projects, including advancements in nano-coating fire retardants and nanofluid pool boiling. His contributions in chemical engineering are well-recognized. 🏫🔬🔥📚

Honors

Prof. SAEID ZEINALI HERI is recognized as one of the top 1% active scientists in Engineering for multiple consecutive years, from 2016 to 2023. His dedication and groundbreaking contributions to the field have earned him this prestigious distinction year after year. His consistent excellence and innovative research have significantly impacted the engineering community, establishing him as a leading figure in his domain. With such an outstanding achievement, Prof. Zeinali Heri continues to inspire and push the boundaries of engineering science. 🏅🔬🌍📚🎓

Industrial Project

Prof. SAEID ZEINALI HERIS has contributed extensively to industrial advancements, especially in natural gas and petrochemical sectors. From 2015 to 2022, his work with Iran Natural Gas Company and other organizations focused on innovative applications of nanotechnology. Projects included the development of fire-retardant nano-coatings for gas refineries, enhancing the efficiency of heaters using functionalized carbon nanotubes, and improving the performance of gas turbine meters. His research also involved investigating the impact of nanoparticles on hydrate formation, wastewater treatment, and the optimization of fuel consumption in gas appliances. His work in nanotechnology continues to shape the industry. 🌱💡🔬⚙️

Research Focus

Prof. SAEID ZEINALI HERIS focuses on experimental and numerical investigations in heat transfer, specifically through the use of nanofluids. His research involves enhancing heat transfer in systems such as photovoltaic thermal units (PV/T), solar stills, and heat exchangers by incorporating nanofluids like Al2O3, TiO2, and silica. He also explores the effects of nanofluids on the thermal performance of engines and radiators. His work spans various applications in energy systems, including solar energy, thermosyphons, and nanolubricants. Additionally, Prof. Heris contributes to studies on exergy analysis, sustainable chemical processes, and thermal efficiencies. 🌡️🔬💧⚡

Publication Top Notes

Experimental investigation of oxide nanofluids laminar flow convective heat transfer

Experimental investigation of convective heat transferof Al2O3/water nanofluid in circular tube

Experimental investigation of the effects of silica/water nanofluid on PV/T (photovoltaic thermal units)

Nanofluids effects on the evaporation rate in a solar still equipped with a heat exchanger

Heat transfer enhancement using Al2O3/water nanofluidin a two-phase closed thermosyphon

Numerical investigation of nanofluid laminar convective heat transfer through a circular tube

Experimental comparison between ZnO and MoS₂ nanoparticles as additives on performance of diesel oil-based nano lubricant

SooHo Yeo | Nanomedicine | Best Researcher Award

Published on 25/01/202525/01/2025 by Top Pharmaceutical

SooHo Yeo | Nanomedicine | Best Researcher Award

Dr SooHo Yeo, College of Pharmacy & Yonsei Institute of Pharmaceutical Sciences, Yonsei University, South Korea

Dr. SooHo Yeo is a research professor at Yonsei University, specializing in pharmaceutics, cosmeceutics, and photodynamic therapy. He holds a Ph.D. in pharmacy from Chung-Ang University, where he focused on artificial skin formulations for topical delivery of adenosine. Dr. Yeo’s research interests include nano/micro-particles, skin absorption, and pharmacokinetic/pharmacodynamic analysis, with applications in cancer treatment and cosmetic clinical tests. He has published numerous studies on nanoparticle-based cancer therapies and anti-adhesive agents. His work contributes significantly to skin irritation, absorption studies, and enhancing anticancer therapies. 🧴💡🔬📚🎓

Publication Profile

Scopus

Education

Dr. SooHo Yeo is a distinguished scholar in the field of pharmacy, having completed his M.S./Ph.D. at the College of Pharmacy, Chung-Ang University, Seoul, Korea, in 2021. His research focused on developing innovative solutions for drug delivery, with his dissertation titled “Artificial Skin Formulation for Topical Delivery of Adenosine.” 🌱💊 His work combines pharmaceutical science and cutting-edge technology to enhance therapeutic efficacy through topical applications. Dr. Yeo’s contributions aim to revolutionize treatments by improving the delivery mechanisms of crucial compounds like adenosine, benefiting patients worldwide. 🧴🌏

Experience

Dr. SooHo Yeo is a dedicated researcher with extensive experience in the field of pharmacy and nanoscience. Since 2023, he has been a Research Professor at the College of Pharmacy, Yonsei University, Incheon, Korea. Prior to this, he served as a Research Professor at the Department of Nanoscience and Engineering, INJE University, Gimhae, Korea, from 2021 to 2023. With a strong focus on advancing research in these fields, Dr. Yeo has made significant contributions to the scientific community. 🔬📚💉🌱

Research Fields

Dr. SooHo Yeo specializes in pharmaceutics and cosmeceutics, focusing on nano/micro-particles, solid dispersion, emulsions, liposomes, films, creams, and inhalers. His research integrates biology and toxicology, including in vitro skin irritation and absorption studies, using cells and reconstructed human epidermis tissues (following OECD guidelines), along with cellular uptake observed through confocal microscopy. Dr. Yeo also conducts pharmacokinetic and pharmacodynamic analysis for anti-cancer and anti-adhesive agents. His cosmetic clinical tests include skin wrinkle and moisture assessments. Additionally, he explores photodynamic therapy, advancing treatments for skin care and cancer therapies. 💉🧴🧬🔬💆‍♀️

Research Focus

Dr. SooHo Yeo’s research primarily focuses on nanotechnology for cancer treatment, particularly in the development of advanced drug delivery systems. His work involves the use of nanoparticles, such as PLGA and solid lipid nanoparticles, to enhance the efficacy of photodynamic therapy (PDT) and chemotherapy. Through innovative drug encapsulation methods, including for agents like Purpurin-18-N-hydroxylimide methyl ester, Dr. Yeo aims to improve therapeutic outcomes in cancer treatment. His studies also explore the use of smart nanoparticles for targeting specific organelles like mitochondria or lysosomes to optimize treatment precision and minimize side effects. 🧬💉🔬💊

Publication Top Notes

Application of PLGA nanoparticles to photodynamic cancer therapy by encapsulating Purpurin-18-N-hydroxylimide methyl ester

4-Hexylresorcinol Loaded Solid Lipid Nanoparticles for Enhancing Anticancer Activity

Enhanced Photodynamic Therapy Efficacy through Solid Lipid Nanoparticle of Purpurin-18-N-Propylimide Methyl Ester for Cancer Treatment

Polysaccharide-based emulsion gels for the prevention of postoperative adhesions and as a drug delivery system using 5-fluorouracil

Design of smart chemotherapy of doxorubicin hydrochloride using nanostructured lipid carriers and solid lipid nanoparticles for improved anticancer efficacy

Long-wavelength absorbing and mitochondria or lysosome organelle-targeting photosensitizers with flexible or rigid terminus for fluorescence imaging and high-performance photodynamic therapy

Improved anticancer efficacy of methyl pyropheophorbide-a–incorporated solid lipid nanoparticles in photodynamic therapy

Transition metal-dependent heavy-atom effect of metallochlorin photosensitizers for enhanced photodynamic therapy

pH-Responsive Nano-transferosomes of Purpurin-18 Sodium Salt and Doxorubicin for Enhanced Anticancer Efficiency by Photodynamic and Chemo Combination Therapy

Long-Wavelength Absorbing Benzimidazolo-Chlorin for Enhanced Photodynamic Therapy

Shoaeb Mohammad Syed | Drug Delivery Systems | Best Researcher Award

Published on 25/01/202525/01/2025 by Top Pharmaceutical

Shoaeb Mohammad Syed | Drug Delivery Systems | Best Researcher Award

Dr Shoaeb Mohammad Syed, Dayanand College of Pharmacy Latur, India

Dr. Shoaeb Mohammad Syed is an Associate Professor at Dayanand College of Pharmacy, Latur, India. With extensive experience in pharmaceutics, formulation development, and novel drug delivery systems, he mentors M.Pharm and Ph.D. students and guides research projects. He has two granted patents and authored several books and research publications. Dr. Syed is actively involved in curriculum development, research mentorship, and academic leadership. His work spans areas like drug delivery, nano drug systems, and quality control. He has also contributed to multiple national and international conferences. 🏫💊📚🔬📜💡🎓

Publication Profile

Google Scholar

Education

Dr. Shoaeb Mohammad Syed holds a PhD in Pharmacy from Govt. College of Pharmacy, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad (2014-2019). He completed his postgraduate studies in Pharmaceutics at Y B Chavan College of Pharmacy, Dr. BAMU Aurangabad, securing 74.45% (2010-2012). He earned his undergraduate degree in Pharmacy from the same institution with 69.79% (2007-2010). Additionally, he obtained a D. Pharmacy from MSBTE Mumbai, achieving 80.60% (2005-2007). Dr. Syed’s academic journey showcases his dedication and expertise in the field of pharmacy. 🎓💊📚

Experience

Dr. Shoaeb Mohammad Syed is an Associate Professor at Dayanand College of Pharmacy, Latur, India, where he leads research, supports faculty programs, and mentors PhD students. He contributes to curriculum development, research projects, and patent filing. Previously, he was an Assistant Professor at Dr. Vedprakash Patil Pharmacy College, developing publications and managing research proposals. His role as a Research Fellow at Govt. College of Pharmacy focused on formulation development and GMP. Dr. Syed has extensive teaching experience across multiple institutions, creating courses, mentoring students, and publishing research. 📚💡📝🔬🎓

Academic Leadership and Mentoring

Dr. Shoaeb Mohammad has demonstrated exemplary leadership in academia through his guidance of Ph.D. students, fostering a supportive environment for academic growth. His active involvement in research proposal development and grant management underscores his dedication to driving innovative research. Dr. Mohammad’s commitment to academic development is further highlighted by his efforts in organizing conferences and workshops, which contribute to the exchange of knowledge and collaboration within the academic community. His work not only supports the academic growth of individuals but also strengthens the overall academic environment, making a lasting impact on the field. 🌍🎤📚

Professional Impact

Dr. Shoaeb Mohammad, known for his expertise in pharmaceutical sciences, has made significant contributions both in academia and the pharmaceutical industry. With a strong presence in scientific writing, he excels in drafting patents and reviewing manuscripts for various journals, ensuring the advancement of pharmaceutical research. His work spans national and international platforms, influencing the development of the field. Dr. Shoaeb’s commitment to innovation and quality in scientific publishing is evident in his dedication to enhancing the global pharmaceutical landscape. His diverse skills and impact continue to shape the future of pharmaceutical sciences. 🏭📑🌍

Research Focus

Dr. Shoaeb Mohammad Syed’s research focus revolves around the development and evaluation of advanced drug delivery systems. His work emphasizes osmotic drug delivery, gastroretentive systems, and transdermal delivery using novel carriers like ethosomes. He has contributed significantly to the analytical validation of pharmaceutical methods, such as UV spectrophotometry and RP-HPLC for drug estimation. His studies also include controlled-release formulations, such as osmotic tablets for sustained drug release, and the application of microsponges in topical drug delivery. Dr. Syed’s expertise in pharmaceutical formulations and analytical techniques aims to enhance drug bioavailability and therapeutic efficacy. 🧪💊📊

Achievements

Dr. Shoaeb Mohammad is a highly accomplished professional with a strong academic background. He qualified GPAT in 2010, was awarded the AICTE scholarship for his post-graduation, and excelled in the NIPERJEE 2010. He received the UGC-MANF fellowship for his PhD and emerged as the winner of Avishkar Research Convention 2019 at Dr. BAMU, Aurangabad, and was selected for the State Level Avishkar 2020 at the University of Mumbai. Dr. Mohammad developed the MDR Shifa Oil (Pain Relief Liniment), which was approved by the FDA Maharashtra, India. 🏆🎓💊👨‍🔬